The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who are refractory to other treatments.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/europe-set-approve-new-immune-thrombocytopenia-therapy-2025a1000s9o?src=rss
Author :
Publish date : 2025-10-17 15:44:00
Copyright for syndicated content belongs to the linked Source.
